perflexane has been researched along with Cancer of Liver in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eun, H; Lee, C; Lee, YJ; Oh, HS; Sim, KH | 1 |
| Hao, J; Wang, R; Wang, Z; Yang, Y; Zhang, N; Zou, H | 1 |
| Chen, Y; Li, P; Ran, H; Wang, D; Wang, Z; Xu, J; You, Y; Zheng, Y | 1 |
| Alpert, E; Choi, SH; Hassanein, TI; Kono, Y; Lucidarme, O; Mattrey, RF; Rose, SC | 1 |
4 other study(ies) available for perflexane and Cancer of Liver
| Article | Year |
|---|---|
Evaluation of the Effect of Perfluorohexane Sulfonate on the Proliferation of Human Liver Cells.
Topics: Alkanesulfonates; Alkanesulfonic Acids; Animals; Carcinoma, Hepatocellular; Cell Proliferation; Endothelial Cells; Environmental Pollutants; Fluorocarbons; Humans; Liver Neoplasms; Sulfonic Acids | 2023 |
Mesoporous composite nanoparticles for dual-modality ultrasound/magnetic resonance imaging and synergistic chemo-/thermotherapy against deep tumors.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cattle; Cell Death; Cell Line, Tumor; Combined Modality Therapy; Doxorubicin; Drug Liberation; Ferrocyanides; Fluorocarbons; High-Intensity Focused Ultrasound Ablation; Liver Neoplasms; Magnetic Resonance Imaging; Nanoparticles; Neoplasms; Porosity; Rabbits | 2017 |
Nanoparticle-enhanced synergistic HIFU ablation and transarterial chemoembolization for efficient cancer therapy.
Topics: Angiography; Animals; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Drug Synergism; Dynamic Light Scattering; Ethiodized Oil; Ferrosoferric Oxide; Fluorocarbons; High-Intensity Focused Ultrasound Ablation; Lactic Acid; Liver Neoplasms; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanocapsules; Photoacoustic Techniques; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proliferating Cell Nuclear Antigen; Rabbits; Transplantation, Heterologous | 2016 |
Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma.
Topics: Albumins; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Female; Fluorocarbons; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2007 |